<DOC>
	<DOCNO>NCT00134147</DOCNO>
	<brief_summary>To assess impact glucose control inhaled insulin patient type 2 diabetes well control 2 oral anti-diabetic agent</brief_summary>
	<brief_title>A Clinical Trial Assessing Impact Availability Inhaled Insulin Glucose Control</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Diabetes mellitus Type 2 Failing two oral antidiabetic agent Asthma , COPD Smoking</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>